$VC

Kim Seungkyung sold $71K of VC

Kim Seungkyung (Senior Vice President) sold 600 shares of VISTEON CORP (VC) at $118.96 on 2026-05-28.

Original reporting
SEC EDGAR · Kim Seungkyung
Published May 29, 2026, 8:40 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 29, 2026, 8:51 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$VC
Neutral
medium confidence
Mentioned
$VC
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VCNeutralLow
01

Why it matters

This disclosure updates insider activity records for VC but does not include earnings, guidance, contracts, litigation, or other company-specific developments.

02

Market read

Traders may monitor for follow-on insider actions, but the filing alone is unlikely to drive a sustained repricing.

03

What to watch

No 10b5-1 plan is cited; however, the article also provides no reason for the sale, so interpreting it as a directional view is low-confidence.

Relevance 6/10Novelty 6/10Timing: Filed after-hours on 2026-05-29; reflects sale executed 2026-05-28.

Background

SEC Form 4 reports insider transactions (officer/direct holdings) and is typically used as a sentiment/positioning datapoint rather than a fundamental catalyst.

Company-level read

Ticker impact

$VCNeutralMedium confidence
Context

Visteon Corp (VC) disclosed an officer open-market sale of 600 shares at $118.96 on 2026-05-28 via SEC Form 4.

Expected impact

Limited near-term impact; any move is likely noise unless followed by additional insider activity or company-specific news.

Evidence & confidence

Insider sales on Form 4 are common and this one is a relatively small value ($71.4K) with no stated fundamental trigger in the article.

Market effects

No clear sector read-through; this is a single-company insider transaction without broader industry signal.

None indicated.

None indicated.

Counterpoint

The sale may be routine liquidity/portfolio rebalancing rather than a bearish signal, especially given the modest dollar amount.

Key entities

  • VISTEON CORP

    Subject of the SEC Form 4 insider transaction; officer sold 600 shares at $118.96.

  • Kim Seungkyung

    Senior Vice President who reported the open-market sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

Med

Visteon Corporation Q3 2026 Earnings Call Summary

Visteon Corporation reported Q3 2026 earnings, highlighting 10 percentage points of market outperformance despite a 5% decline in vehicle production. The company addressed $77 million in warranty charges and managed inflation in PCBs. For 2027, Visteon anticipates $500 million in incremental costs and aims to maintain EBITDA targets through customer recoveries. China sales are expected to grow in Q4 2026, driven by high-performance compute launches.

Med

Visteon (VC) Q3 2026 Earnings Call Transcript

Visteon (VC) reported Q3 2026 earnings, highlighting a $200M share repurchase and sales growth despite market challenges. Sales grew in Americas, Europe, and Asia (excluding China), with China sales expected to recover in Q4. The company launched 21 new products, including high-value cockpit technologies, and secured $1B in new business bookings, targeting $6B for the year. Strategic wins include programs with Toyota, Maruti Suzuki, and Tata Motors.

$VCMedAI 8/10

What Visteon (VC) Said on Its Q3 Earnings Call

Visteon (VC) reported Q3 earnings, noting regional sales trends and product launches. Sales rose 14% in Asia excluding China, but faced challenges in the Americas and China. The company expects China sales to grow in Q4 with new launches. Visteon launched 21 products and booked $1B in new business, maintaining its $6B annual target. It updated guidance, raising full-year sales to $3.8B-$3.85B but lowering adjusted EBITDA to $370M-$410M. Q4 sales are expected to be $940M, flat YoY.